Rural Access to Physical Therapy for Osteoarthritis Rehabilitation - Pilot
RAPTOR
1 other identifier
interventional
27
1 country
1
Brief Summary
This is a pilot study involving a hybrid in-person + telerehabilitation intervention for rural adults with knee osteoarthritis. The primary purpose is to demonstrate feasibility and safety of the RAPTOR program, and the secondary purpose is to estimate clinical effectiveness of the RAPTOR program on participants' pain, function, and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 29, 2021
CompletedFirst Posted
Study publicly available on registry
November 10, 2021
CompletedStudy Start
First participant enrolled
December 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2024
CompletedOctober 4, 2024
October 1, 2024
2.8 years
September 29, 2021
October 2, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Recruitment Target
The investigators' recruitment target is 27 participants, and this outcome will be successful upon enrollment of the 27th participant. This outcome will be used as one component of the overall summary outcome of "feasibility", which is defined as success in all 5 primary outcomes.
Through study completion, which is anticipated to take approximately 1 year.
Visit Attendance (75% or higher)
The percentage of physical therapy visits attended, divided by the number of scheduled visits (10) for each participant. This outcome will be successful if mean visit attendance among all participants is at least 75%. This outcome will be used as one component of the overall summary outcome of "feasibility", which is defined as success in all 5 primary outcomes.
Through study completion, which is anticipated to take approximately 1 year.
Telehealth Usability Questionnaire
The Telehealth Usability Questionnaire (5/7) is a self-reported questionnaire used to assess participant satisfaction with the telehealth services received. It contains 21 items, each rated on a 7-point scale ranging from "strongly disagree" (1 point) to "strongly agree" (7 points). The items are summed to create a total score ranging from 7 - 147 points, with higher numbers indicating greater usability of the telehealth services. This outcome will be successful if the average item rating across all participants is at least 5/7. This outcome will be used as one component of the overall summary outcome of "feasibility", which is defined as success in all 5 primary outcomes.
Measured at post-treatment (last visit, approximately 10 weeks after enrollment)
Study-Related Adverse Events / Serious Adverse Events
This outcome will be successful if there are zero study-related adverse events and serious adverse events among the 27 participants. This outcome will be used as one component of the overall summary outcome of "feasibility", which is defined as success in all 5 primary outcomes.
Through study completion, which is anticipated to take approximately 1 year.
Clinically Important Improvement on ONE Functional Outcome Measure
The final component of the overall primary outcome of feasibility will be met if each participant achieves mean improvement on at least one functional outcome measure that exceeds the minimum clinically important difference. This may occur on a self-reported outcome measure (the KOOS, described below) or a performance-based outcome measure (30-second chair stand test, timed stair climb test, Timed Up and Go test, 40-meter fast-paced walk test, 6-minute walk test). All of these outcome measures are individually considered to be Secondary Outcome Measures and are described below in greater detail.
Baseline (measured at first visit) and post-treatment (measured at last visit, approximately 10 weeks later)
Secondary Outcomes (6)
Functional outcome measure: 30-second chair stand test
Baseline (measured at first visit) and post-treatment (measured at last visit, approximately 10 weeks later)
Functional outcome measure: Timed stair climb test
Baseline (measured at first visit) and post-treatment (measured at last visit, approximately 10 weeks later)
Functional outcome measure: Timed Up and Go (TUG)
Baseline (measured at first visit) and post-treatment (measured at last visit, approximately 10 weeks later)
Functional outcome measure: 40-meter fast-paced walk test
Baseline (measured at first visit) and post-treatment (measured at last visit, approximately 10 weeks later)
Functional outcome measure: 6-minute walk
Baseline (measured at first visit) and post-treatment (measured at last visit, approximately 10 weeks later)
- +1 more secondary outcomes
Study Arms (1)
RAPTOR Physical Therapy Intervention
EXPERIMENTALRAPTOR intervention: hybrid in-person + telehealth physical therapy care for rural-dwelling individuals with knee osteoarthritis
Interventions
All participants will receive the RAPTOR intervention, which includes 2 in-person physical therapy visits and 8 telerehabilitation visits. Participants will attend an initial in-person PT evaluation to meet their provider, receive a hands-on assessment of their impairments and functional limitations, and receive instruction in an initial home exercise program. The remainder of their visits will be completed remotely, using a telerehabilitation platform. At the conclusion of care, the patient will return to the clinic for a follow-up assessment and training on their final home exercise program.
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (1)
University of Pittsburgh
Pittsburgh, Pennsylvania, 15219, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Allyn Bove, DPT, PhD
University of Pittsburgh
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- This is a single-group study; therefore, no masking is possible.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 29, 2021
First Posted
November 10, 2021
Study Start
December 20, 2021
Primary Completion
September 30, 2024
Study Completion
September 30, 2024
Last Updated
October 4, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- Data will be made available upon the conclusion of the study for up to seven years upon request.
- Access Criteria
- Requests for data sharing must be agreed to by the investigators and the relevant institutional review board.
Only fully deidentified data will be made available to other researchers upon request and approval by the investigators and the relevant institutional review board.